{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:22:16Z","timestamp":1794270136153,"version":"4.9.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/1026"],"award-info":[{"award-number":["PI15\/1026"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijantimicag.2026.107947","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:04:02Z","timestamp":1785341042000},"page":"107947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial prophylaxis regimens in joint replacement surgery: Susceptibility and PK\/PD target attainment"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-6162","authenticated-orcid":false,"given":"Alba","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Mur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Puig-Verdi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2174-9874","authenticated-orcid":false,"given":"Anna","family":"G\u00e1llego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Crusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9562-514X","authenticated-orcid":false,"given":"Luisa","family":"Sorl\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Horcajada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-2838","authenticated-orcid":false,"given":"Ferran","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-013X","authenticated-orcid":false,"given":"Natividad","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107947_bib0001","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/jama.2022.24075","article-title":"Surgical site infection prevention: a review","volume":"329","author":"Seidelman","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0002","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1086\/676022","article-title":"Strategies to prevent surgical site infections in acute care hospitals: 2014 update","volume":"35","author":"Anderson","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0003","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12178-020-09653-9","article-title":"Contemporary strategies to prevent infection in hip and knee arthroplasty","volume":"13","author":"Batty","year":"2020","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0004","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3390\/jcm9072190","article-title":"Prevention of prosthetic joint infection: from traditional approaches towards quality improvement and data mining","volume":"9","author":"Gallo","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jamasurg.2024.0429","article-title":"Preventing surgical site infections in the era of escalating antibiotic resistance and antibiotic stewardship","volume":"159","author":"Long","year":"2024","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0006","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/AAC.46.9.3026-3030.2002","article-title":"Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy","volume":"46","author":"Zelenitsky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0007","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3390\/antibiotics12121738","article-title":"Effective antimicrobial prophylaxis in surgery: the relevance and role of pharmacokinetics-pharmacodynamics","volume":"12","author":"Zelenitsky","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0008","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eimc.2020.02.017","article-title":"Executive summary of the Consensus Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and of the Spanish Association of Surgeons (AEC) in antibiotic prophylaxis in surgery","volume":"39","author":"del Toro L\u00f3pez","year":"2021","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/675289","article-title":"Activity of commonly used antimicrobial prophylaxis regimens against pathogens causing coronary artery bypass graft and arthroplasty surgical site infections in the United States, 2006\u20132009","volume":"35","author":"Berr\u00edos-Torres","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0011","doi-asserted-by":"crossref","first-page":"732.e1","DOI":"10.1016\/j.cmi.2016.05.004","article-title":"Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study","volume":"22","author":"Benito","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11091244","article-title":"Microbiological trends and antibiotic susceptibility patterns in patients with periprosthetic joint infection of the hip or knee over 6 years","volume":"11","author":"Fr\u00f6schen","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0013","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cmi.2022.10.029","article-title":"Cefazolin resistance among gram-negative bacilli isolated from prosthetic joint infections: a French observational study","volume":"29","author":"Leroy","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cmi.2019.10.007","article-title":"Vancomycin prophylaxis in prosthetic joint surgery?","volume":"26","author":"Yusuf","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0015","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/jcm8050673","article-title":"The different microbial etiology of prosthetic joint infections according to route of acquisition and time after prosthesis implantation, including the role of multidrug-resistant organisms","volume":"8","author":"Benito","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0016","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1302\/0301-620X.103B1.BJJ-2020-1381.R1","article-title":"The EBJIS definition of periprosthetic joint infection","volume":"103-B","author":"McNally","year":"2021","journal-title":"Bone Joint J"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/antibiotics10010018","article-title":"Intraoperative bacterial contamination and activity of different antimicrobial prophylaxis regimens in primary knee and hip replacement","volume":"10","author":"Rivera","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0019","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/antibiotics13010100","article-title":"Surgical antibiotic prophylaxis: a proposal for a global evidence-based bundle","volume":"13","author":"Sartelli","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","article-title":"The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients","volume":"50","author":"Ulldemolins","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jat\/28.3.187","article-title":"Gentamicin and tobramycin binding to human serum in vitro","volume":"28","author":"Bailey","year":"2004","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0022","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJMoa2301401","article-title":"Trial of vancomycin and cefazolin as surgical prophylaxis in arthroplasty","volume":"389","author":"Peel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0023","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/AAC.06246-11","article-title":"Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective?","volume":"56","author":"Peel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0024","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.eimc.2018.12.013","article-title":"Dual prophylaxis with teicoplanin and cefazolin in the prevention of prosthetic joint infection","volume":"37","author":"Barbero-Allende","year":"2019","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0025","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1128\/AAC.03949-14","article-title":"Prophylaxis with teicoplanin and cefuroxime reduces the rate of prosthetic joint infection after primary arthroplasty","volume":"59","author":"Tornero","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0026","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.arth.2015.09.051","article-title":"Expanded gram-negative antimicrobial prophylaxis reduces surgical site infections in hip arthroplasty","volume":"31","author":"Bosco","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0027","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/microorganisms13051002","article-title":"Incidence of PJI in total knee arthroplasty patients following expanded gram-negative antibiotic prophylactic protocol","volume":"13","author":"Sarfraz","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0028","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/cid\/cis027","article-title":"Vancomycin for surgical prophylaxis?","volume":"54","author":"Crawford","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/antibiotics12010040","article-title":"The clinical outcome of early periprosthetic joint infections caused by Staphylococcus epidermidis and managed by surgical debridement in an era of increasing resistance","volume":"12","author":"Shabana","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/sur.2020.293","article-title":"Bactericidal in vitro activity of a tissue-achievable concentration of cefazolin against methicillin-resistant Staphylococcus aureus","volume":"22","author":"Chen","year":"2021","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0031","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/civ308","article-title":"Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals","volume":"61","author":"McDanel","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0032","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.arth.2025.04.079","article-title":"Cefazolin is associated with a lower periprosthetic joint infection risk than alternative antibiotic regimens following total hip arthroplasty","volume":"40","author":"Carter","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0033","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2106\/JBJS.21.00445","article-title":"Antibiotic prophylaxis with cefazolin is associated with lower shoulder periprosthetic joint infection rates than non-cefazolin alternatives","volume":"104","author":"Marigi","year":"2022","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0034","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/SLA.0b013e31825fa398","article-title":"Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive Staphylococcus aureus surgical site infections: report from Australian surveillance data (VICNISS)","volume":"256","author":"Bull","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0035","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s11999-017-5302-0","article-title":"Vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin","volume":"475","author":"Kheir","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0036","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.arth.2021.03.035","article-title":"Incomplete administration of intravenous vancomycin prophylaxis is common and associated with increased infectious complications after primary total hip and knee arthroplasty","volume":"36","author":"Feder","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0037","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.5435\/JAAOS-D-22-00122","article-title":"Documented penicillin allergies should not preclude use of preoperative cefazolin in hip and knee arthroplasty","volume":"31","author":"Kurcz","year":"2023","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.ijantimicag.2026.107947_bib0038","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1097\/CORR.0000000000001497","article-title":"Is patient-reported penicillin allergy independently associated with increased risk of prosthetic joint infection after total joint arthroplasty of the hip, knee, and shoulder?","volume":"478","author":"Wu","year":"2020","journal-title":"Clin Orthop Relat Res"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926002347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:39:21Z","timestamp":1794267561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926002347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0924857926002347"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107947","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial prophylaxis regimens in joint replacement surgery: Susceptibility and PK\/PD target attainment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}],"article-number":"107947"}}